These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25732891)

  • 1. Clinical exacerbation developing during treatment of cutaneous leishmaniasis: an id reaction?
    Yeşilova Y; Özbilgin A; Turan E; Altın Sürücü H; Aksoy M
    Turkiye Parazitol Derg; 2014 Dec; 38(4):281-2. PubMed ID: 25732891
    [No Abstract]   [Full Text] [Related]  

  • 2. Photo quiz. Healthy student with a papule. New World cutaneous leishmaniasis.
    Wilson ME; Lucchina LC
    Clin Infect Dis; 2001 Sep; 33(6):816, 899-900. PubMed ID: 11575257
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR; Weerakoon HS
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
    Hartzell JD; Aronson N
    N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
    [No Abstract]   [Full Text] [Related]  

  • 5. Milia and cutaneous leishmaniasis.
    Del Giudice P
    Br J Dermatol; 2007 May; 156(5):1088. PubMed ID: 17381448
    [No Abstract]   [Full Text] [Related]  

  • 6. Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort.
    Renert-Yuval Y; Enk CD; Murad S; Yofe V; Gozal D; Molho-Pessach V
    J Am Acad Dermatol; 2019 Oct; 81(4):1013-1015. PubMed ID: 30731176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Facial cutaneous leishmaniasis from a vacation to the south].
    Király C
    Duodecim; 1995; 111(12):1104-6. PubMed ID: 9213545
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with New World cutaneous leishmaniasis in travelers.
    Scope A; Trau H; Anders G; Barzilai A; Confino Y; Schwartz E
    J Am Acad Dermatol; 2003 Oct; 49(4):672-8. PubMed ID: 14512915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [American cutaneous leishmaniasis: special features in diagnosis and therapy].
    Bormann G; William T; Schulz A; Marsch W; Gaber G
    Dtsch Med Wochenschr; 2003 Oct; 128(40):2065-8. PubMed ID: 14523685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cutaneous leishmaniasis.
    Hepburn NC
    Curr Opin Infect Dis; 2001 Apr; 14(2):151-4. PubMed ID: 11979125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of localized cutaneous leishmaniasis].
    Buffet P; Caumes E; Gentilini M
    Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous leishmaniasis in a returning UK traveller.
    Singh Raghunath R; Yong AS; Igali L; Tan E; Lockwood D
    Postgrad Med J; 2014 Sep; 90(1067):540-1. PubMed ID: 25053817
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis.
    Brummitt CF; Porter JA; Herwaldt BL
    Clin Infect Dis; 1996 May; 22(5):878-9. PubMed ID: 8722966
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cutaneous leishmaniasis patients with pentostam via intralesion infiltration.
    Nagaty IM; Lashin AH
    J Egypt Soc Parasitol; 2000 Apr; 30(1):177-82. PubMed ID: 10786029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis.
    Wortmann GW; Aronson NE; Byrd JC; Grever MR; Oster CN
    Clin Infect Dis; 1998 Sep; 27(3):509-12. PubMed ID: 9770149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 2. Lupoid leishmaniasis.
    Bowling JC; Vega-Lopez F
    Clin Exp Dermatol; 2003 Nov; 28(6):683-4. PubMed ID: 14616851
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
    Sharma VK; Prasad HR; Sethuraman G; Khaitan BK
    Indian J Dermatol Venereol Leprol; 2007; 73(1):53-4. PubMed ID: 17314452
    [No Abstract]   [Full Text] [Related]  

  • 19. Leishmaniasis recidivans in a Palestinian Bedouin child.
    Al-Jawabreh A; Nasereddin A
    Skinmed; 2007; 6(5):250-2. PubMed ID: 17786107
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.